Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells

por Alam, Muhammad Wasi, Borenäs, Marcus, Lind, Dan E., Cervantes-Madrid, Diana, Umapathy, Ganesh, Palmer, Ruth H., Hallberg, Bengt
Publicado 2019

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells

por Alam, Muhammad Wasi, Persson, Camilla Ulrika, Reinbothe, Susann, Kazi, Julhash U., Rönnstrand, Lars, Wigerup, Caroline, Ditzel, Henrik Jorn, Lykkesfeldt, Anne E., Påhlman, Sven, Jögi, Annika
Publicado 2016